Morgan Stanley
BXMX

Morgan Stanley’s Nuveen S&P 500 Buy-Write Income Fund BXMX Stock Holding History

Morgan Stanley’s Portfolio BXMX Stock Details BXMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,037,265
Closed -$177M – 8321
2025
Q4 		$177M Buy
12,037,265
+236,500
+2% +$3.4M 0.01% 1016
2025
Q3 		$170M Sell
11,800,765
-34,238
-0.3% -$484K 0.01% 1025
2025
Q2 		$164M Buy
11,835,003
+235,555
+2% +$3.1M 0.01% 978
2025
Q1 		$152M Buy
11,599,448
+340,833
+3% +$4.69M 0.01% 988
2024
Q4 		$158M Buy
11,258,615
+64,079
+0.6% +$888K 0.01% 959
2024
Q3 		$154M Buy
11,194,536
+155,539
+1% +$2.08M 0.01% 967
2024
Q2 		$149M Buy
11,038,997
+97,023
+0.9% +$1.27M 0.01% 935
2024
Q1 		$145M Sell
10,941,974
-11,708,158
-52% -$153M 0.01% 952
2023
Q4 		$291M Buy
22,650,132
+11,093,146
+96% +$139M 0.01% 930
2023
Q3 		$146M Buy
11,556,986
+230,727
+2% +$3.05M 0.01% 841
2023
Q2 		$151M Sell
11,326,259
-211,604
-2% -$2.79M 0.01% 844
2023
Q1 		$151M Buy
11,537,863
+392,311
+4% +$5.13M 0.02% 817
2022
Q4 		$141M Buy
11,145,552
+73,225
+0.7% +$945K 0.02% 835
2022
Q3 		$132M Buy
11,072,327
+375,987
+4% +$4.98M 0.02% 756
2022
Q2 		$132M Buy
10,696,340
+520,024
+5% +$7M 0.02% 772
2022
Q1 		$145M Buy
10,176,316
+427,754
+4% +$6M 0.02% 655
2021
Q4 		$143M Buy
9,748,562
+208,057
+2% +$3.06M 0.02% 704
2021
Q3 		$136M Buy
9,540,505
+593,043
+7% +$8.69M 0.02% 677
2021
Q2 		$129M Buy
8,947,462
+601,470
+7% +$8.47M 0.02% 718
2021
Q1 		$113M Buy
8,345,992
+216,016
+3% +$2.79M 0.02% 703
2020
Q4 		$105M Buy
8,129,976
+32,413
+0.4% +$389K 0.02% 701
2020
Q3 		$91.3M Sell
8,097,563
-208,521
-3% -$2.38M 0.02% 623
2020
Q2 		$91.4M Buy
8,306,084
+117,003
+1% +$1.27M 0.02% 587
2020
Q1 		$82.7M Sell
8,189,081
-751,941
-8% -$9.36M 0.02% 546
2019
Q4 		$123M Buy
8,941,022
+71,853
+0.8% +$972K 0.03% 525
2019
Q3 		$116M Buy
8,869,169
+118,054
+1% +$1.54M 0.03% 509
2019
Q2 		$117M Buy
8,751,115
+90,976
+1% +$1.2M 0.03% 513
2019
Q1 		$114M Sell
8,660,139
-24,368
-0.3% -$315K 0.03% 496
2018
Q4 		$105M Buy
8,684,507
+121,261
+1% +$1.6M 0.03% 507
2018
Q3 		$123M Sell
8,563,246
-224,954
-3% -$3.23M 0.03% 526
2018
Q2 		$124M Buy
8,788,200
+89,392
+1% +$1.25M 0.03% 491
2018
Q1 		$116M Buy
8,698,808
+45,274
+0.5% +$625K 0.03% 517
2017
Q4 		$123M Buy
8,653,534
+99,695
+1% +$1.4M 0.03% 509
2017
Q3 		$120M Buy
8,553,839
+162,447
+2% +$2.25M 0.04% 480
2017
Q2 		$116M Buy
8,391,392
+488,917
+6% +$6.77M 0.04% 507
2017
Q1 		$105M Buy
7,902,475
+303,411
+4% +$4M 0.03% 549
2016
Q4 		$96.7M Sell
7,599,064
-63,181
-0.8% -$803K 0.03% 555
2016
Q3 		$101M Buy
7,662,245
+362,451
+5% +$4.74M 0.03% 523
2016
Q2 		$95.1M Buy
7,299,794
+78,480
+1% +$1M 0.03% 519
2016
Q1 		$91.9M Buy
7,221,314
+23,082
+0.3% +$283K 0.04% 505
2015
Q4 		$96.7M Buy
7,198,232
+632,631
+10% +$8.1M 0.04% 506
2015
Q3 		$79.4M Buy
6,565,601
+110,569
+2% +$1.41M 0.03% 567
2015
Q2 		$82.8M Buy
6,455,032
+465,603
+8% +$5.97M 0.03% 592
2015
Q1 		$76.7M Buy
5,989,429
+1,206,683
+25% +$15.6M 0.03% 611
2014
Q4 		$57.9M Buy
4,782,746
+4,249,246
+796% +$54M 0.02% 769
2014
Q3 		$6.8M Sell
533,500
-4,752
-0.9% -$61.8K ﹤0.01% 2362
2014
Q2 		$7.06M Buy
538,252
+102,971
+24% +$1.32M ﹤0.01% 2349
2014
Q1 		$5.5M Buy
435,281
+45,813
+12% +$572K ﹤0.01% 2502
2013
Q4 		$4.89M Buy
389,468
+21,183
+6% +$263K ﹤0.01% 2580
2013
Q3 		$4.45M Buy
368,285
+39,380
+12% +$490K ﹤0.01% 2544
2013
Q2 		$4.13M Buy
+328,905
New +$4.19M ﹤0.01% 2512

Other funds holding BXMX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return
CBT
CoreFirst Bank & Trust Topeka, Kansas $201M AUM 24.67% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
AWM
Ameliora Wealth Management Zurich, Switzerland $337M AUM 21.71% 1-Year Est. Return

Morgan Stanley's BXMX Position: Q1 2026 in Review

Morgan Stanley sold out of Nuveen S&P 500 Buy-Write Income Fund (BXMX) in Q1 2026, closing a stake of 12,037,265 shares — an estimated $177M sold.

Morgan Stanley first reported a position in BXMX in Q2 2013 and held it in 51 quarters. The position peaked at $291M in Q4 2023. 4 funds tracked by Wall St. Rank hold BXMX as of Q1 2026.

  • Morgan Stanley reported no remaining Nuveen S&P 500 Buy-Write Income Fund position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 12,037,265 Nuveen S&P 500 Buy-Write Income Fund shares in Q1 2026, an estimated $177M.
  • Morgan Stanley first reported a position in Nuveen S&P 500 Buy-Write Income Fund in Q2 2013 and held it in 51 quarters.
  • Morgan Stanley's Nuveen S&P 500 Buy-Write Income Fund position peaked at $291M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Nuveen S&P 500 Buy-Write Income Fund as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.